Type 2 Diabetes Mellitus Clinical Trial
Official title:
A Peer Support Program to Enhance Treatment Adherence in Patients With Type 2 Diabetes Mellitus
Diabetes Mellitus (DM) affects patients' quality of life in different dimensions. Therefore,
it is considered a priority to design and create specialized intervention programs in order
to prevent and decrease complications. The peer support program studies have shown to
Increase adherence to treatment and the proportion of patients with adequate long-term
metabolic control.
The benefits that these programs bring are the social and emotional support in the daily
management of the disease through shared experiences and communication in a continuous way.
There are only a few peer support programs in Mexico, thus it is required to investigate the
effects of their implementation in our environment to promote empowerment and maintain
long-term lifestyle changes. The present study has the objective to enhance self-care
behaviors and health empowerment in patients with diabetes through peer support.
The traditional model of attention has not been able to face the diabetes epidemic mainly
because it is treated like an acute disease instead of like a chronic condition. Given that
it requires a continuous and integrated management that cares for all the aspects of the
patient's disease, it is fundamental that the patients learn to live with diabetes, and to
manage it effectively to improve their life quality and reduce the risks of long term
complications.
The peer support programs include people who live with the same condition (patients,
relatives and friends) who have received training related to their treatment, becoming an
important social, emotional and practical support in the daily care of chronic diseases.They
become comfortable enough as to share their emotions and experiences with other patients with
their same condition.
Many studies have shown that the patients with diabetes who commit to provide peer support to
others also improve their self-care and glycemic long-term control.
The meetings with group leaders consist discussions among the patients where they share
experiences and solutions to barriers.
The Center of Comprehensive Care for the Patient with Diabetes (CAIPaDi) was created with the
objective of investigating about new strategies to promote empowerment, self-efficacy and the
reach of metabolic control in order to prevent diabetes complications (protocol "Validation
of an integrated attention model for the patient with type 2 diabetes" reference number
1198). The inclusion criteria are: less than 5 years of diagnosis of diabetes, absence of
chronic complications, not smoking and having a relative to join them in all the sessions.
The program consists of 4 initial visits, one per month, and includes attention from 9
specialties: endocrinology, psychology, nutrition, ophthalmology, diabetes education,
odontology, physical activity, foot care and psychiatry. Upon conclusion of the fourth visit,
a counter-reference of each patient is sent to their corresponding particular physician. In
this report, each specialty explains in a detailed manner the strengths and opportunity areas
of the patient. Afterwards, the patient is given an appointment a year after concluding the
first phase of the program (visit 5) and a year after this visit (visit 6).
Description of the interventions
1. Identification of the "group leaders"
Patients who fulfill the eligibility criteria will be invited and asked to sign the informed
consent, afterwards they will attend 7 training sessions of 60 minutes each, the following
topics will be assessed in each of them:
1. Reinforcement of the metabolic control goals and most common problems in diabetes.
2. Self-care activities: detection and appropriate treatment of hypoglycemia, glucose
self-monitoring, foot care and actions on concomitant diseases.
3. Adherence to meal plan
4. Structuration of activities to increase physical activity or diminish sedentarism and
measurement methods (steps per day, identification of exercise intensity levels)
5. Emotional aspects of diabetes (duel and motivation stages)
6. Adhesion to pharmacologic treatment (medications and insulin)
Each session will be arranged by a team researcher and will be structured in the following
way:
10 minutes: reminder of activities and resolution of doubts from the previous session 50
minutes: new subject of each session
After the patient has completed the training, an objective structured clinical evaluation
will be performed. The patients who approve the evaluation will receive a group management
session where they will obtain the necessary skills to motivate and transmit information to
the rest of the group.
Phase 2: Integration of patient groups All the patients who finish the fourth visit in the
centre will be invited, those who accept will be randomized into participants or control
patients.
Each group will be formed by 2 group leaders and 5 patients. The minimum number of
participants per session will be 2 (one leader and one patient). Five sessions are projected,
one every 2 months, where the next topics will be reviewed in each of them:
1. Identification of motivation and duel stages
2. Reinforcement of metabolic control goals
3. Self-care activities:detection and appropriate treatment of hypoglycemia, glucose
self-monitoring, foot care and actions on concomitant diseases and insulin application.
4. Enhancement of adhesion to simplified meal plan and recognition of portions
5. Structuration of activities to boost physical activity and/or reduce sedentarism and how
to measure it (steps per day and identification of exercise intensity levels)
Motivational messages and reminders will be created and sent by WhatsApp (cross-platform
instant messaging application) weekly to patients, controls and group leaders to strengthen
adhesion to integral treatment.
Every session will be carried out in the facilities of the centre, where the leaders will
share their experiences with the rest of the group to reinforce self-care activities.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02771093 -
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT02545842 -
Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
|
Phase 4 | |
Recruiting |
NCT03436212 -
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
|
N/A | |
Completed |
NCT03244800 -
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
|
Phase 2 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Withdrawn |
NCT02769091 -
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06065540 -
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
|
Phase 3 | |
Recruiting |
NCT05008276 -
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
|
||
Completed |
NCT04091373 -
A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide
|
Phase 1 | |
Completed |
NCT03296800 -
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT06212778 -
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
|
||
Completed |
NCT05979519 -
Fresh Carts for Mom's to Improve Food Security and Glucose Management
|
N/A | |
Recruiting |
NCT05579314 -
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Terminated |
NCT03684642 -
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
|
Phase 3 | |
Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT03644134 -
A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns
|
N/A | |
Completed |
NCT05295160 -
Fasting-Associated Immune-metabolic Remission of Diabetes
|
N/A | |
Completed |
NCT02836873 -
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
|
Phase 3 | |
Completed |
NCT02226003 -
Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)
|
Phase 3 |